33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HB-300, a novel arenavirus-based cancer immunotherapy in patients with metastatic castration-resistant prostate cancer
    Meeting Abstract

    Chism, D. D.; Saraiya, B.; Dorff, T. B.; Curti, B. D.; Posadas, E. M.; St. Paul, C.; Mukhopadhyay, S.; Desai, L.; Lauterbach, H.; Nassirpour, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 3 multicenter study to evaluate the safety and efficacy of padeliporfin vascular targeted photodynamic therapy (VTP) in treatment of low-grade (LG) upper tract urothelial cancer (UTUC)
    Meeting Abstract

    Coleman, J.; Margulis, V.; Scherz, A. J.; Krasnopolskaya, I.; Alpert, G.; Jobert, V.; Preise, D.; Shore, N. D.; UCM301 Investigators
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • STAR-221: A randomized, open-label, multicenter, phase 3 trial of domvanalimab, zimberelimab, and chemotherapy versus nivolumab and chemotherapy in previously untreated, locally advanced, unresectable or metastatic gastric, gastroesophageal junction, and esophageal adenocarcinoma
    Meeting Abstract

    Klempner, S. J.; Shitara, K.; Sison, A.; Scott, J.; Wishengrad, D.; Ronayne, J.; Rhee, J.; Mitra, S.; Nuyten, D. S. A.; Janjigian, Y. Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non–muscle-invasive bladder cancer (NMIBC)
    Meeting Abstract

    Dsouza, N.; Gaffney, C.; Hernandez, C.; Moran, P.; Worth, K.; McCarter, M.; de Jesus, M. R.; Solit, D. B.; Sarungbam, J.; Al-Ahmadie, H. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1b, open-label, two-part safety, tolerability, and efficacy study of a soluble beta-glucan (odetiglucan) in combination with a CD40 agonistic monoclonal antibody (CDX-1140) in patients with metastatic pancreatic adenocarcinoma whose disease did not progress during first-line (1L) chemotherapy
    Meeting Abstract

    O'Hara, M. H.; Wattenberg, M. M.; Garrido-Laguna, I.; O'Reilly, E. M.; Yellin, M. J.; Keler, T.; Gargano, M. A.; Niles, N.; Drees, J.; Bose, N.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Alliance A021804: A prospective, multi-institutional phase II trial evaluating temozolomide versus temozolomide and olaparib for advanced pheochromocytoma and paraganglioma
    Meeting Abstract

    Del Rivero, J.; Perez, K.; Geyer, S. M.; Khalil, M. F.; Vijendran, A.; Kordaris-Corkill, A.; Shergill, A.; Spencer, K. R.; Soares, H. P.; Lopez, C. D.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase IIa/IIb, open-label trial of BI 907828, an MDM2–p53 antagonist, in patients with locally advanced/metastatic biliary tract carcinoma or pancreatic ductal adenocarcinoma: Brightline-2
    Meeting Abstract

    Goyal, L.; Harding, J. J.; Ueno, M.; Lamarca, A.; Macarulla, T.; Yamamoto, N.; Hu, J.; Teufel, M.; Maerten, A.; Vogel, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Randomized phase II trial of olaparib + pembrolizumab vs olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA 1/2+) pathogenic variants: SWOG S2001
    Meeting Abstract

    Chung, V.; Guthrie, K. A.; Pishvaian, M. J.; Reiss, K. A.; Lowy, A. M.; Sohal, D.; Colby, S.; Sharon, E.; Allegra, C. J.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Alliance A021806: A phase III trial evaluating perioperative versus adjuvant therapy for resectable pancreatic cancer
    Meeting Abstract

    Chawla, A.; Shi, Q.; Ko, A. H.; Beg, S.; Varghese, A. M.; Behrman, S. W.; Bloomston, M.; Ahmed, F. S.; Frankel, W. L.; Dixon, J. G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Autologous cytotoxic T-cell receptor T cell therapy (SCG101) against hepatitis B surface antigen phase I/II trial for patients with advanced hepatitis B-related hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Yong, W. P.; Chang, S. L.; Fan, J.; Toh, H. C.; Yau, T.; Choo, S.; Wang, J.; Kusuma, N.; Ma, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save